Shaun Murphy

Shaun Murphy is currently the Vice President and Head of Nonclinical Research and Development at Abpro, where Shaun oversees pharmacology and toxicology functions and leads various programs such as the SARS-CoV-2 neutralizing antibody program. Prior to their current role, Shaun served as the Director of Nonclinical Research and Development, managing the preclinical services business unit. Shaun has experience as a Study Director at Toxikon Corporation and as a Research Fellow at Harvard Medical School. Shaun holds a PhD in Pathobiology from Brown University and a BS in Biology from UMass Boston.